Free Trial

Aldeyra Therapeutics (ALDX) SEC Filings & 10K Form

Aldeyra Therapeutics logo
$4.76 -0.18 (-3.64%)
(As of 11/20/2024 ET)

Recent Aldeyra Therapeutics SEC Filings

DateFilerForm TypeView
11/18/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM
Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
10/21/2024
7:22 PM
Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:15 PM
Aldeyra Therapeutics (Issuer)
Alfieri Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
8:02 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:24 PM
Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:24 PM
Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:07 PM
Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
4:45 PM
Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
6:06 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
11:15 PM
Aldeyra Therapeutics (Filer)
Form EFFECT
04/22/2024
3:11 PM
Aldeyra Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:13 PM
Aldeyra Therapeutics (Filer)
Form DEFA14A
04/22/2024
3:18 PM
Aldeyra Therapeutics (Filer)
Form ARS
04/08/2024
4:32 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:22 PM
Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
6:01 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:01 PM
Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:04 PM
Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:07 PM
Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:11 PM
Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
7:43 PM
Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
6:12 PM
Aldeyra Therapeutics (Subject)
Brady Todd C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:48 PM
Aldeyra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2024
3:40 PM
Aldeyra Therapeutics (Filer)
Form S-8 POS
01/04/2024
6:00 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
6:05 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
6:16 AM
Aldeyra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALDX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners